# Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking for Compassionate Treatment in Pediatric Patients With Progressive Keratoconus

> **NCT00925327** · PHASE2 · UNKNOWN · sponsor: **Peschke Meditrade, GmbH** · enrollment: 7 (estimated)

## Conditions studied

- Progressive Keratoconus

## Interventions

- **OTHER:** Corneal collagen cross-linking with riboflavin/UVA light

## Key facts

- **NCT ID:** NCT00925327
- **Lead sponsor:** Peschke Meditrade, GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 7 (ESTIMATED)
- **Last updated:** 2009-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00925327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00925327, "Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking for Compassionate Treatment in Pediatric Patients With Progressive Keratoconus". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00925327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*